Expanded Access Program for GBM Subjects
NCT06676891
·
clinicaltrials.gov ↗
AVAILABLE
Status
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
RZ-001
Sponsor
Rznomics, Inc.